Humana Inc. (HUM) Stock

About Humana Inc.

Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.

Humana Inc. is led by CEO James A. Rechtin, employs 65,680 people, headquartered in Louisville, US, publicly traded since 1981.

Humana Inc. (HUM) stock trades at $364.54 with a market capitalization of $43.77B. The stock is valued at a price-to-earnings (P/E) ratio of 29.34, price-to-book of 1.88, price-to-sales of 0.32. Over the past 52 weeks the stock has ranged between $163.11 and $416.50, and currently trades 12.5% below its 52-week high. It pays a dividend yielding 0.96%.

On profitability, Humana Inc. generates a return on equity (ROE) of 6.28%, return on capital employed of 8.19%, an operating margin of 1.12%, a net profit margin of 0.82%.

In its most recent fiscal year, Humana Inc. reported annual revenue of $129.7B, net profit of $1.2B, revenue has compounded at 10.9% a year over the last five years, profit at -18.8% a year.

The balance sheet shows a debt-to-equity ratio of 0.75, a current ratio of 0.72, total assets of $48.8B, $4.2B in cash and equivalents.

HUM has an average daily trading volume of 1,553,203 shares, a beta of 0.77 (less volatile than the overall market).

Official website: www.humana.com